OOIR: Observatory of International Research

Papers

(The TQCC of Climacteric is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Osteoporosis and fractures in women: the burden of disease	94
Hormone replacement therapy – where are we now?	67
Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink	44
CO₂ laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial	38
The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis	33
The effects of phytoestrogens on postmenopausal health	33
Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition	32
Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy	32
Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence	28
Cardiometabolic health in premature ovarian insufficiency	27
Fracture risk assessment by the FRAX model	27
Bone health 2022: an update	27
Hormone replacement therapy and cervical cancer: a systematic review of the literature	24
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years	24
Premature or early bilateral oophorectomy: a 2021 update	24
Skin, hair and beyond: the impact of menopause	24
Endometriosis-associated cancer	24
Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline?	22
Dietary intake and menopausal symptoms in postmenopausal women: a systematic review	20
The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries	20
Selective estrogen receptor modulators and bone health	20
Medical treatment of osteoporosis	19
Estrogen receptor α: a critical role in successful female cognitive aging	17
Cognitive profiles in perimenopause: hormonal and menopausal symptom correlates	16
Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review	15

Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis	14
Health-care providers’ views of menopause and its management: a qualitative study	14
Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women	13
The 2023 Practitioner’s Toolkit for Managing Menopause	12
Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study)	12
A pas de deux of osteoporosis and sarcopenia: osteosarcopenia	12
Premenopausal osteoporosis	12
Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study	12
A research primer for studies of cognitive changes across the menopause transition	12
Lasers in the era of evidence-based medicine	11
Transgender health and the impact of aging and menopause	11
Clinical practice of traditional Chinese medicine for the treatment of postmenopausal osteoporosis: a literature review	11
Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study	11
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency	11
Physiologic and psychosocial changes of the menopause transition in US Latinas: a narrative review	10
Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy	10
New insights into the diagnosis and management of bone health in premature ovarian insufficiency	10
Novel approaches to fertility restoration in women with premature ovarian insufficiency	10
Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study	10
Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms	10
Neurokinin 3 receptor antagonists – prime time?	10
Menopause, hormone therapy and cognition: maximizing translation from preclinical research	10
Postmenopausal hyperandrogenism	10
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause	9
Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser	9
Precision hormone therapy: identification of positive responders	9
PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis	9
Update on bone health: the International Menopause Society White Paper 2021	9
Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study	9
The effects of hormone replacement therapy on the microbiomes of postmenopausal women	9
First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency	9
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk	9
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study	8
Sustainability of vaginal estrogens for genitourinary syndrome of menopause – a systematic review	8
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women	8
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study	8
Reproductive milestones across the lifespan and cardiovascular disease risk in women	8
Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea	8
The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review	8
The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman	8
Osteoanabolic therapy for osteoporosis in women	7
Polycystic ovary syndrome: associations with cardiovascular disease	7
Quality of life in menopausal women in the workplace – a systematic review	7
The impact of micronized progesterone on cardiovascular events – a systematic review	7
Premature ovarian insufficiency: a toolkit for the primary care physician	7
Association of menopausal status and symptoms with depressive symptoms in middle-aged Chinese women	7
The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects	7
Hormone therapy for postmenopausal osteoporosis management	7
Understanding of and clinical approach to cardiometabolic transition at the menopause	7
Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial	7

Bioidentical hormones	7
Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case–control study	7
Peer review: the cornerstone of scientific publishing integrity	7
Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis	6
Changes in high-sensitivity C-reactive protein levels and metabolic indices according to grip strength in Korean postmenopausal women	6
Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment	6
Compounded bioidentical menopausal hormone therapy – a physician perspective	6
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA	6
Pulmonary embolism in menopausal hormone therapy: a population-based register study	6
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women	6
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy	6
Sequential treatment in vulvovaginal atrophy	6
Impact of progesterone on the gastrointestinal tract: a comprehensive literature review	6
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause	6
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies	6
Testosterone for women: certainties and uncertainties	6
Weight gain in menopause: systematic review of adverse events in women treated with black cohosh	6
Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?	6
Vulvodynia – an evolving disease	6
Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women	6
E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation	6
Er:YAG laser in hysterectomized women with stress urinary incontinence: a VELA retrospective cohort, non-inferiority study	6
Evaluation of the relationship between homocysteine levels and bone mineral density in postmenopausal women	6
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis	6